Thus, many of the patients heterozygous for 1 of the 38 tested mutations, who have clinical manifestations characteristic of CF and positive iontophoresis, remain undiagnosed, because the parents cannot afford the cost of CFTR gene sequencing. The gene discussed is CFTR; the disease is cystic fibrosis.